Paul Hastings Advised J.P. Morgan as Sole Book-Running Manager in Secondary Offering by Certain Stockholders of Harmony Biosciences
November 01, 2024
November 01, 2024
LOS ANGELES, California, Nov. 1 -- Paul Hastings, a law firm, issued the following news:
Paul Hastings LLP advised J.P. Morgan as the sole book-running manager in connection with the secondary offering by certain selling stockholders of Harmony Biosciences Holdings, Inc. The offering is expected to close on November 1, 2024, subject to customary closing conditions.
Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and partner . . .
Paul Hastings LLP advised J.P. Morgan as the sole book-running manager in connection with the secondary offering by certain selling stockholders of Harmony Biosciences Holdings, Inc. The offering is expected to close on November 1, 2024, subject to customary closing conditions.
Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and partner . . .